<p><b>A, B:</b> Comparison of MMP-2 (A) and MMP-9 (B) mRNA and protein expression in the LF of the LSCS and control groups. mRNA levels were normalized to <i>18S rRNA</i> levels. The value in the control group was set as 1. <b>C:</b> Immunohistochemical analysis of MMP-2 and -9 expressions in LF tissue from patients with LSCS (left) and control subjects (right). The inset in the left panel for MMP-2 shows a high-magnification view of the area enclosed by the dashed line. Arrowheads indicate MMP-positive cells. Scale bar, 100 μm. <b>D:</b> Correlation between MMP-2 mRNA (left) and protein (right) expression and LF thickness. Data represent the mean ± SEM (LSCS, n = 31 and control, n = 21 for mRNA assay; and n = 14 per group for protein assay...
<p>A: MMP-2 was negative in the adjacent noncancerous tissues. B: MMP-2 was positive in cancerous ti...
<p>During the experiment stages, MMP-1, 2 and 9 had different changes in expression level. MMP-1 was...
<p>(A)–(C) The VEGF or MMP-2/9 concentrations were analyzed in the sera from patients with SPMS, RRM...
<p>(A) mRNA of MMP-2, MMP-9 and VEGF were analyzed by RT-PCR in control and LPS (2 µg/ml, 48 h) grou...
<p>Western blot analysis showing the expression levels of MMP-2 and MMP-9 in control, CCI, and ipsil...
<p>Data are expressed as the activity calculated by densitometric analyses. The gene expression is s...
<p>(a) Quantitative real-time PCR of MMP-9 mRNA. 2 µM and 4 µM WIN decreased MMP-9 mRNA to 66% and 5...
<p><b>A:</b> Correlation between <i>MMP-2</i> mRNA expression and elastic fiber area. The minimum va...
<p>A & B. Total LV lysates (50 µg), prepared from sham and non-infarct (NINF) and infarct (INF) LV r...
<p>(<b>A</b>) Immunostaining of POU5F1 and MMP-2 observed by confocal scanning microscopy. (<b>B</b>...
<p>Experiments were run in triplicate. *<i>P</i><0.05 was considered statistically significant.</p
<p><b>A</b>) is pooled data for qPCR analysis for MMP-9 expression of the LV-shRNA-ADAMTS-1 (<b>LV</...
<p>(A) Real-time PCR analysis of <i>MMP9</i> in MCF-7 cells. <i>MMP9</i> gene expression was determi...
<p>A) Analysis of MMP3 expression by qRT-PCR in BM-MSCs (black bars), HUCPVCs (white bars) or AT-MSC...
<p>(<b>A</b>) Antibody-array analysis of protein expression in supernatants (<b>A</b>) from 2D monol...
<p>A: MMP-2 was negative in the adjacent noncancerous tissues. B: MMP-2 was positive in cancerous ti...
<p>During the experiment stages, MMP-1, 2 and 9 had different changes in expression level. MMP-1 was...
<p>(A)–(C) The VEGF or MMP-2/9 concentrations were analyzed in the sera from patients with SPMS, RRM...
<p>(A) mRNA of MMP-2, MMP-9 and VEGF were analyzed by RT-PCR in control and LPS (2 µg/ml, 48 h) grou...
<p>Western blot analysis showing the expression levels of MMP-2 and MMP-9 in control, CCI, and ipsil...
<p>Data are expressed as the activity calculated by densitometric analyses. The gene expression is s...
<p>(a) Quantitative real-time PCR of MMP-9 mRNA. 2 µM and 4 µM WIN decreased MMP-9 mRNA to 66% and 5...
<p><b>A:</b> Correlation between <i>MMP-2</i> mRNA expression and elastic fiber area. The minimum va...
<p>A & B. Total LV lysates (50 µg), prepared from sham and non-infarct (NINF) and infarct (INF) LV r...
<p>(<b>A</b>) Immunostaining of POU5F1 and MMP-2 observed by confocal scanning microscopy. (<b>B</b>...
<p>Experiments were run in triplicate. *<i>P</i><0.05 was considered statistically significant.</p
<p><b>A</b>) is pooled data for qPCR analysis for MMP-9 expression of the LV-shRNA-ADAMTS-1 (<b>LV</...
<p>(A) Real-time PCR analysis of <i>MMP9</i> in MCF-7 cells. <i>MMP9</i> gene expression was determi...
<p>A) Analysis of MMP3 expression by qRT-PCR in BM-MSCs (black bars), HUCPVCs (white bars) or AT-MSC...
<p>(<b>A</b>) Antibody-array analysis of protein expression in supernatants (<b>A</b>) from 2D monol...
<p>A: MMP-2 was negative in the adjacent noncancerous tissues. B: MMP-2 was positive in cancerous ti...
<p>During the experiment stages, MMP-1, 2 and 9 had different changes in expression level. MMP-1 was...
<p>(A)–(C) The VEGF or MMP-2/9 concentrations were analyzed in the sera from patients with SPMS, RRM...